William W. Bachovchin PhD

Dr. Bachovchin serves as Executive Vice President and Chief Scientist and member of the board of directors of Arisaph pharmaceuticals since he co-founded the company in 1999. He was also a co-founder of Point Therapeutics which was a publically traded biotechnology company prior to its merger with Dara BioSciences. Dr. Bachovchin is also Professor of Biochemistry at Tufts University School of Medicine.

Dr Bachovchin received a BS degree in Biology from Wake Forest University a doctoral degree in Chemistry from The California Institute of Technology, and did postdoctoral work at Harvard Medical School before arriving at Tufts. Dr. Bachovchin is an author on more than 100 peer reviewed journal articles, and an inventor on more than 30 issued patents as well as numerous pending applications.

Dr. Bachovchin is a leader in the areas of NMR spectroscopy, enzymes mechanisms and drug design and discovery, especially in areas pertaining to the post proline cleaving family of enzymes. To date three drugs designed by Dr. Bachovchin have entered human clinical trials and several more are in late stage preclinical testing.